Testing a test for Alzheimer disease

Neurology

Volumn 68, Issue 7, 2007, Pages 482-483

  Bateman, Randall J ^a   Eidelberg, David ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; FLUORODEOXYGLUCOSE;

ALZHEIMER DISEASE; BIOCHEMISTRY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EDITORIAL; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; IMMUNIZATION; MEMORY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PSYCHOMETRY; QUANTITATIVE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID; COGNITION; DIAGNOSTIC IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; MEMORY; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 33847024952     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000257671.88772.f1     Document Type: Editorial

References (9)

1. Edison P, Archer HA, Hinz R, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease. An [11C]PIB and [18F]FDG PET study. Neurology 2007;68:501-508.
2. Klunk W, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319.
3. Kemppainen NM, Aalto S, Wilson IA, et al. Voxel-based analysis of PET amyloid ligand [C-11]PIB uptake in Alzheimer disease. Neurology 2006;67:1575-1580.
4. Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452.
5. Price J, Ko A, Wade M, Tsou S, McKeel D, Morris J. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease. Arch Neurol 2001;58:1395-1402.
6. Selkoe DJ. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 2004;140:627-638.
7. Fagan AM, Mintun MA, Mach RH, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A beta(42) in humans. Ann Neurol 2006;59:512-519.
8. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 2006;12:856-861.
9. Fox NC, Black RS, Gilman S, et al. Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 2005;64:1563-1572.